The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 6,563 | 135,413 | SH | SOLE | 135,413 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,481 | 1,531,312 | SH | SOLE | 1,531,312 | 0 | 0 | ||
| AKOUOS INC | COM | 00973J101 | 44,460 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 68,696 | 3,075,014 | SH | SOLE | 3,075,014 | 0 | 0 | ||
| APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 28,911 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 44,779 | 1,810,000 | SH | SOLE | 1,810,000 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 73,547 | 3,153,797 | SH | SOLE | 3,153,797 | 0 | 0 | ||
| ATRECA INC | CL A COM | 04965G109 | 31,690 | 1,489,185 | SH | SOLE | 1,489,185 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 59,458 | 2,103,950 | SH | SOLE | 2,103,950 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 16,999 | 4,748,300 | SH | SOLE | 4,748,300 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 12,020 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 25,178 | 837,885 | SH | SOLE | 837,885 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 2,006 | 737,612 | SH | SOLE | 737,612 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 15,064 | 859,802 | SH | SOLE | 859,802 | 0 | 0 | ||
| CYCLERION THERAPEUTICS INC | COM | 23255M105 | 16,207 | 2,742,276 | SH | SOLE | 2,742,276 | 0 | 0 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 17,738 | 733,561 | SH | SOLE | 733,561 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 69,139 | 2,721,993 | SH | SOLE | 2,721,993 | 0 | 0 | ||
| EQUILLIUM INC | COM | 29446K106 | 174 | 59,014 | SH | SOLE | 59,014 | 0 | 0 | ||
| EVELO BIOSCIENCES INC | COM | 299734103 | 6,125 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| EXICURE INC | COM | 30205M101 | 4,083 | 1,673,301 | SH | SOLE | 1,673,301 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 21,267 | 619,855 | SH | SOLE | 619,855 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 2,318 | 379,945 | SH | SOLE | 379,945 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 16,138 | 882,353 | SH | SOLE | 882,353 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 41,923 | 19,230,769 | SH | SOLE | 19,230,769 | 0 | 0 | ||
| GLYCOMIMETICS INC | COM | 38000Q102 | 7,103 | 1,889,000 | SH | SOLE | 1,889,000 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 1,212 | 25,300 | SH | Call | SOLE | 25,300 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 5,160 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| KALEIDO BIOSCIENCES INC | COM | 483347100 | 233 | 31,374 | SH | SOLE | 31,374 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 8,260 | 220,216 | SH | SOLE | 220,216 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 75,119 | 4,608,529 | SH | SOLE | 4,608,529 | 0 | 0 | ||
| LIFESCI ACQUISITION CORP | UNIT 03/31/2025 | 53228P208 | 3,300 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MAGENTA THERAPEUTICS INC | COM | 55910K108 | 3,380 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| MEIRAGTX HLDGS PLC | COM | G59665102 | 1,187 | 94,819 | SH | SOLE | 94,819 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 40,856 | 357,849 | SH | SOLE | 357,849 | 0 | 0 | ||
| MORPHIC HLDG INC | COM | 61775R105 | 76,767 | 2,837,973 | SH | SOLE | 2,837,973 | 0 | 0 | ||
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 58,709 | 3,536,684 | SH | SOLE | 3,536,684 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 89,122 | 2,642,218 | SH | SOLE | 2,642,218 | 0 | 0 | ||
| PLIANT THERAPEUTICS INC | COM | 729139105 | 42 | 1,300 | SH | SOLE | 1,300 | 0 | 0 | ||
| PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 5,472 | 367,218 | SH | SOLE | 367,218 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 98,603 | 9,426,640 | SH | SOLE | 9,426,640 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 8,950 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| REPARE THERAPEUTICS INC | COM | 760273102 | 1,551 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ROYALTY PHARMA PLC | SHS CL A | G7709Q104 | 2,428 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 3,567 | 1,432,664 | SH | SOLE | 1,432,664 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 33,022 | 5,033,861 | SH | SOLE | 5,033,861 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 14,189 | 1,828,492 | SH | SOLE | 1,828,492 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 40,605 | 519,119 | SH | SOLE | 519,119 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 147,280 | 4,547,072 | SH | SOLE | 4,547,072 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 1,004 | 50,809 | SH | SOLE | 50,809 | 0 | 0 | ||